Synthesis and Structure−Activity Relationships of Long-acting β2Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach
Citations Over TimeTop 10% of 2010 papers
Abstract
A series of saligenin beta(2) adrenoceptor agonist antedrugs having high clearance were prepared by reacting a protected saligenin oxazolidinone with protected hydroxyethoxyalkoxyalkyl bromides, followed by removal of the hydroxy-protecting group, alkylation, and final deprotection. The compounds were screened for beta(2), beta(1), and beta(3) agonist activity in CHO cells. The onset and duration of action in vitro of selected compounds were assessed on isolated superfused guinea pig trachea. Compound 13f had high potency, selectivity, fast onset, and long duration of action in vitro and was found to have long duration in vivo, low oral bioavailability in the rat, and to be rapidly metabolized. Crystalline salts of 13f (vilanterol) were identified that had suitable properties for inhaled administration. A proposed binding mode for 13f to the beta(2)-receptor is presented.
Related Papers
- Adrenergic influence on iris stromal pigmentation: evidence for alpha-adrenergic receptors.(1982)
- → Nitric Oxide Is Involved in the Response of the Isolated Intact and Epithelium-Denuded Rat Trachea to the β<sub>2</sub> Adrenergic Receptor Agonist Salbutamol(2010)6 cited
- → Lipolysis studies on human fat cells: The value of subtype specific adrenergic compounds in functional characterization of antilipolytic adrenergic receptors(1992)
- β-Adrenergic Regulation of α3-Adrenergic Receptors in the Central Nervous System(1980)